Traxoprodil decreases pentylenetetrazol-induced seizures

Ana Paula Naspolini, Ariane Rubin Cocco, Felipe Villa Martignoni, Mauro Schneider Oliveira, Ana Flávia Furian, Leonardo Magno Rambo, Maribel Antonello Rubin, Susan Barron, Carlos Fernando Mello

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Polyamines, including spermidine, facilitate seizures by positively modulating N-methyl- d-aspartate receptors (NMDAr). Although NMDAr antagonists decrease seizures, it remains to be determined whether traxoprodil, a selective antagonist at the NR2B subunit of the NMDAr, decreases seizures and whether spermidine facilitates pentylenetetrazol (PTZ)-induced seizures. Adult male Wistar rats were injected in the lateral ventricle with 0.9% NaCl (1 μl, i.c.v.), spermidine (0.02, 0.2 or 2. nmol/site, i.c.v.) or traxoprodil (0.2, 2 or 20. nmol, i.c.v.) and with PTZ (35 or 70. mg/kg, i.p.). The effect of orally administered traxoprodil (60. mg/kg, p.o.) on seizures was also investigated. Latencies to clonic and generalized seizures, as well the total time spent in seizures were recorded by behavioral and electrographic methods (EEG). Spermidine (2. nmol/site; i.c.v.) facilitated the seizures induced by a sub-threshold dose of PTZ (35. mg/kg; i.p.), but did not alter seizure activity induced by a convulsant dose of PTZ (70. mg/kg; i.p.). Traxoprodil (20. nmol i.c.v.) increased the latency to generalized tonic-clonic seizures induced by PTZ (70. mg/kg; i.p.). Traxoprodil (60. mg/kg, p.o.) increased the latency to clonic and generalized seizures, and decreased the total time spent in seizures. These results support the role for the NR2B subunit in PTZ-induced seizures.

Original languageEnglish
Pages (from-to)12-19
Number of pages8
JournalEpilepsy Research
Volume100
Issue number1-2
DOIs
StatePublished - Jun 2012

Bibliographical note

Funding Information:
All the experiments reported herein comply with the current laws of Brazil. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines and none of the authors has any conflict of interest to disclose. The authors are grateful to Pfizer Inc. (New York, NY, USA) for generously donating traxoprodil. This study was supported by CNPq (grant numbers: 504363/2007-7 , 301558/2007-8 , 477836/2007-0 , 563222/2008-5 , 500502/2009-9 , 301552/2007-0 and 141164/2010-7 ), FAPERGS ( 10/0685-8 ) and CAPES . CF Mello, MS Oliveira, MA Rubin, LM Rambo, AR Cocco and AP Naspolini are recipients of CNPq fellowships.

Keywords

  • CP-101,606
  • Pentylenetetrazol
  • Polyamines
  • Seizures
  • Spermidine
  • Traxoprodil

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Traxoprodil decreases pentylenetetrazol-induced seizures'. Together they form a unique fingerprint.

Cite this